Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 13413

Case report
Table of Contents - Year : 2018 | Month : March | Volume : 12 | Issue : 3 | Page : OD01 - OD02

Refractory Thrombotic Thrombocytopenic Purpura: A Case Report OD01-OD02

Mohammed Shafi Abdulsalam, Venkateshwaran Radhakrishnan, Prabu Pandurangan

Dr. Prabu Pandurangan,
Greams Road, Apollo Hospital, Chennai-600001, Tamil Nadu, India.

Thrombotic thrombocytopenic purpura is a thrombotic microangiopathy. Clinical manifestations occur due to decreased perfusion to the internal organs. Usually it responds to pulse steroids and plasma exchange. Various therapies are available for refractory cases which respond to N-Acetyl cysteine, cyclosporin, rituximab, bortezomib and caplacizumab. We report a case of refractory Thrombotic Thrombocytopenic Purpura (TTP) in a 29-years-old female showed improvement with the use of rituximab (anti-CD 20 monoclonal antibody), who presented with history of fever and one episode of seizure.